Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Recs

1
Player Avatar Ludraman1 (< 20) Submitted: 9/20/2007 1:28:36 PM : Outperform Start Price: $29.33 MRX Score: +34.85

dermatology products treating acne, acne-related conditions, fungal
infections, skin discoloration, and inflammatory and hyperproliferative skin diseases, such as psoriasis
and topical dermatitis.

People are increasingly concerned with appearance and willing to spend more money on anything that affects the skin.

Medical spending continues in a downturn too.

Featured Broker Partners


Advertisement